Gemini Therapeutics, Inc. (NASDAQ:GMTX - Get Free Report)'s share price shot up 3.6% during trading on Friday . The company traded as high as $53.30 and last traded at $52.71. 396,554 shares changed hands during mid-day trading, an increase of 109% from the average session volume of 189,291 shares. The stock had previously closed at $50.86.
Gemini Therapeutics Stock Up 3.6%
The firm has a 50 day moving average price of $45.47 and a 200 day moving average price of $53.39. The stock has a market capitalization of $2.28 billion, a PE ratio of -52.71 and a beta of -0.12.
About Gemini Therapeutics
(
Get Free Report)
Gemini Therapeutics, Inc, a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD). Its lead candidate is GEM103, a recombinant form of the human complement factor H protein to treat dry AMD patients.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Gemini Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Gemini Therapeutics wasn't on the list.
While Gemini Therapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
